Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy
Clinical trial NCT02953184 · UNKNOWN
Trial details
- NCT number
- NCT02953184
- Sponsor
- Jilin University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2019-11-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.